{
    "title": "Pfizer plans expanded coronavirus vaccine trials, sees 'negligible' hit from outbreak",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8264923/Pfizer-sticks-forecast-quarter-profit-boost-Ibrance.html",
    "date": "2020-04-28",
    "keywords": [
        "vaccine",
        "pfizer",
        "pandemic",
        "impact",
        "revenue",
        "joseph",
        "tuesday",
        "coronavirus",
        "emergency",
        "use",
        "approval",
        "company",
        "forecast",
        "share",
        "virus",
        "quarter",
        "covid19",
        "inc",
        "october",
        "profit",
        "office",
        "fear",
        "executive",
        "albert",
        "bourla",
        "conference",
        "call",
        "patient",
        "partnership",
        "biontech",
        "safety",
        "fall",
        "year",
        "companys",
        "management",
        "confidence",
        "guidance",
        "analyst",
        "contrast",
        "merck",
        "co",
        "boost",
        "demand",
        "pneumonia",
        "prevnar",
        "illness",
        "course",
        "commitment",
        "offpatent",
        "business",
        "drugmaker",
        "mylan",
        "nv",
        "street",
        "reporting",
        "sibi",
        "vishwadha",
        "chander",
        "bengaluru",
        "michael",
        "erman",
        "maplewood",
        "chakrabarty",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}